Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression-Reference-Cited by-同舟云学术

Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression

Published:2021-03-10 Issue:3 Volume:44 Page:673-687
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Hussain S. Mazher,Kansal Rita G.,Alvarez Marcus A.,Hollingsworth T. J.,Elahi Abul,Miranda-Carboni Gustavo,Hendrick Leah E.,Pingili Ajeeth K.,Albritton Lorraine M.,Dickson Paxton V.,Deneve Jeremiah L.,Yakoub Danny,Hayes D. Neil,Kurosu Michio,Shibata David,Makowski Liza,Glazer Evan S.^ORCID

Funder

Society for Surgery of the Alimentary Tract

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-021-00594-0.pdf

Reference79 articles.

1. R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2019. CA Cancer J Clin 69, 7–34 (2019)

2. The Cancer Genome Atlas Research Network, Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185–203 e113 (2017)

3. V.P. Balachandran, M. Luksza, J.N. Zhao, V. Makarov, J.A. Moral, R. Remark, B. Herbst, G. Askan, U. Bhanot, Y. Senbabaoglu, D.K. Wells, C.I.O. Cary, O. Grbovic-Huezo, M. Attiyeh, B. Medina, J. Zhang, J. Loo, J. Saglimbeni, M. Abu-Akeel, R. Zappasodi, N. Riaz, M. Smoragiewicz, Z.L. Kelley, O. Basturk, M. Gonen, A.J. Levine, P.J. Allen, D.T. Fearon, M. Merad, S. Gnjatic, C.A. Iacobuzio-Donahue, J.D. Wolchok, R.P. DeMatteo, T.A. Chan, B.D. Greenbaum, T. Merghoub, S.D. Leach, Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature 551, 512–516 (2017)

4. L. Danilova, W.J. Ho, Q.F. Zhu, T. Vithayathil, A. De Jesus-Acosta, N.S. Azad, D.A. Laheru, E.J. Fertig, R. Anders, E.M. Jaffee, M. Yarchoan, Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival. Cancer Immunol Res 7, 886–895 (2019)

5. S.M. Hussain, L.F. Reed, B.A. Krasnick, G. Miranda-Carboni, R.C. Fields, Y. Bi, A. Elahi, A. Ajidahun, P.V. Dickson, J.L. Deneve, W.G. Hawkins, D. Shibata, E.S. Glazer, IL23 and TGF-β diminish macrophage associated metastasis in pancreatic carcinoma. Sci Rep 8, 5808 (2018)

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF-κB Mediated Disruption of Pancreatic Signaling Pathways and its Implications for the Risk of Pancreatic Adenocarcinoma: a systematic review;2024-08-08

2. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer;Molecular Pharmaceutics;2024-07-25

3. Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review;Cell Biochemistry and Biophysics;2024-07-02

4. Senescence-associated secretory phenotype (SASP) and uterine fibroids: Association with PD-L1 activation and collagen deposition;Ageing Research Reviews;2024-06

5. Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma;Cancers;2024-04-11